| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 09/14/1999 | US5952006 Drug preparations for treating impotency |
| 09/14/1999 | US5952005 Particles of a morphine salt coated with a water insoluble barrier layer formed from ethyl cellulose, (meth)acrylic ester copolymers or waxes and a plasticizer; once daily dosage; reduced plasma concentration fluctuation |
| 09/14/1999 | US5952004 Emulsified drug delivery systems |
| 09/14/1999 | US5952003 Terazosin dosage form capsules containing solid fill which are bioequivalent to a reference liquid-filled terazosin capsule dosage form, but have improved shelf life and are simpler to manufacture |
| 09/14/1999 | US5952001 Preparing pharmaceutical, dermatological or cosmetic preparations for the prevention or treatment of allergic manifestations such as skin allergy, bronchial asthma, or inflammation, or as free radical scavengers |
| 09/14/1999 | US5952000 Transdermal drug delivery system: an active pharmaceutical permeant in a penetration enhancing system of fatty acid esters of lactic acid salts such as sodium lauroyl lactylate and a pressure sensitive adhesive carrier vehicle |
| 09/14/1999 | US5951999 Transdermal pressure sensitive adhesive drug delivery system |
| 09/14/1999 | US5951993 Comprising a lower alcohol and water and solid hydrophobic and hydrophilc emulsifiers; skin disinfection such as presurgical hand preps, patient preps, lotions and presurgical scrub replacement |
| 09/14/1999 | US5951971 Eye-drops for treatment of eye disorders and surrounding area comprising cyclosporin and surfactant selected from polyoxyethylene fatty acid esters, polyoxyethylene alkylphenol ether and polyoxyethylene alkyl ethers |
| 09/14/1999 | US5951600 Medical devices using electrosensitive gels |
| 09/14/1999 | US5951538 Gas generating device for delivering beneficial agents to a body cavity |
| 09/14/1999 | US5950830 Packaging for patches |
| 09/14/1999 | CA2167483C Hair styling compositions containing a silicone grafted polymer and low level of a volatile hydrocarbon solvent |
| 09/14/1999 | CA2004177C Readily absorbable drug formulation of nb-818 |
| 09/14/1999 | CA2001044C Oral liquid pharmaceutical compositions of sulindac |
| 09/12/1999 | CA2265211A1 Making dosage units using low shear granulation |
| 09/11/1999 | CA2231968A1 Method of producing a nicotine medicament |
| 09/10/1999 | WO1999044735A1 Method and device for capsulating microbial, plant and animal cells or biological and chemical substances |
| 09/10/1999 | WO1999044733A1 Method of particle formation |
| 09/10/1999 | WO1999044643A1 Implantable particles for tissue bulking and the treatment of gastroesophageal reflux disease, urinary incontinence, and skin wrinkles |
| 09/10/1999 | WO1999044642A1 Pharmaceutical compositions and their use |
| 09/10/1999 | WO1999044637A1 Method and apparatus for enhancing flux rates of a fluid in a microporated biological tissue |
| 09/10/1999 | WO1999044635A1 Enhancement of immunity by intranasal inoculation of il-12 |
| 09/10/1999 | WO1999044631A1 Topical composition containing human epidermal growth factor |
| 09/10/1999 | WO1999044622A1 Inorganic nitrite and organic acid in combination as topical antiviral composition |
| 09/10/1999 | WO1999044617A1 Activated vitamin d3 emulsion-type lotions |
| 09/10/1999 | WO1999044614A1 Pharmaceutical composition containing cefuroxime axetil stable for moisture absorption |
| 09/10/1999 | WO1999044604A1 Pharmaceutical compositions containing the phospholipase inhibitor sodium [[3-(2-amino-1,2-dioxoethyl)-2-ethyl-1-phenylmethyl)-1h-indol-4-yl]oxy]acetate |
| 09/10/1999 | WO1999044594A1 Fat emulsions for inhalational administration |
| 09/10/1999 | WO1999044592A1 Anti-asthma therapy |
| 09/10/1999 | WO1999044591A1 Extended release dosage form |
| 09/10/1999 | WO1999044590A1 Sustained-release preparation for aii antagonist, production and use thereof |
| 09/10/1999 | WO1999044589A1 Oral pellet with immediate release comprising glycerides subjected to polyglycolysis, method for making same |
| 09/10/1999 | WO1999044588A2 Method for producing solid, spherical forms containing pharmaceutical active agents in a binder matrix |
| 09/10/1999 | WO1999044587A1 Apparatus and method for diluting nasal sprays containing addictive compounds |
| 09/10/1999 | WO1999044586A1 Topical formulation of oil-in-water type as a carrier for providing a reduced irritant effect |
| 09/10/1999 | WO1999044585A1 Topical formulation of the oil-in-water type, comprising galactolipid material as emulsifier, with a prolonged effect of an incorporated active substance |
| 09/10/1999 | WO1999044584A1 Emulsion preconcentrates containing cyclosporin or a macrolide |
| 09/10/1999 | WO1999044583A2 Methods and devices for modulating the immune response |
| 09/10/1999 | WO1999044582A2 Nontoxic vernix compositions and method of producing |
| 09/10/1999 | WO1999044581A2 Pharmaceutical composition of topiramate |
| 09/10/1999 | WO1999044580A1 Fast disintegrating tablets |
| 09/10/1999 | WO1999044578A1 Formulations with an anti-viral effect |
| 09/10/1999 | WO1999044573A1 Composition and means for treating dry mouth |
| 09/10/1999 | WO1999044557A1 Hydrogels containing cross-linked carboxylic acid-hydroxy alcoholpolymers for use in drug delivery |
| 09/10/1999 | WO1999033486A9 Composition and method for dermal and transdermal administration of a cytokine |
| 09/10/1999 | WO1999032156A3 Novel sterilization process for pharmaceutical suspensions |
| 09/10/1999 | WO1999031262A3 Needle-free injection of formulated nucleic acid molecules |
| 09/10/1999 | WO1999027990A3 Stereospecific delivery of a drug using electrotransport |
| 09/10/1999 | WO1999027949A9 METHOD OF SUPPRESSING β-AMYLOID-RELATED CHANGES IN ALZHEIMER'S DISEASE |
| 09/10/1999 | CA2637760A1 Method and apparatus for enhancing flux rates of a fluid in a microporated biological tissue |
| 09/10/1999 | CA2327716A1 Method and device for capsulating microbial, plant and animal cells or biological and chemical substances |
| 09/10/1999 | CA2323731A1 Topical formulation of oil-in-water type as a carrier for providing a reduced irritant effect |
| 09/10/1999 | CA2322850A1 Topical formulation of the oil-in-water type, comprising galactolipid material as emulsifier, with a prolonged effect of an incorporated active substance |
| 09/10/1999 | CA2322796A1 Pharmaceutical compositions containing the phospholipase inhibitor sodium ¬¬3-(2-amino-1,2-dioxoethyl)-2-ethyl-1-phenylmethyl)-1h-indol-4-yl|oxy|acetate |
| 09/10/1999 | CA2322629A1 Method for producing solid, spherical forms containing pharmaceutical active agents in a binder matrix |
| 09/10/1999 | CA2322450A1 Formulations having an antiviral action |
| 09/10/1999 | CA2322435A1 Methods and devices for modulating the immune response |
| 09/10/1999 | CA2322337A1 Enhancement of immunity by intranasal inoculation of il-12 |
| 09/10/1999 | CA2322199A1 Inorganic nitrite and organic acid in combination as topical antiviral composition |
| 09/10/1999 | CA2321732A1 Nontoxic vernix compositions and method of producing |
| 09/09/1999 | DE19812753C1 Pharmaceutical or nutritive composition comprising a metal yeast and an active agent embedded in a matrix |
| 09/09/1999 | DE19809719A1 Aqueous dispersion for binder and coating for medicine |
| 09/09/1999 | DE19809304A1 Formulierungen mit antiviraler Wirkung Formulations having antiviral activity |
| 09/09/1999 | DE19809242A1 Verfahren zur Herstellung von festen, sphärischen Formkörpern, enthaltend pharmazeutische Wirkstoffe in einer Bindemittelmatrix A process for the preparation of solid, spherical moldings containing pharmaceutical active ingredients in a binder matrix |
| 09/09/1999 | DE19806966A1 Verfahren und Vorrichtung zum Einbringen einer Vielzahl vereinzelter folienförmiger Darreichungsformen in einen Spender unter Bildung eines viellagigen Stapels Method and apparatus for applying a plurality of isolated sheet-like dosage forms into a dispenser to form a multi-layer stack |
| 09/08/1999 | EP0940138A1 Lubrication assistant and process for the preparation of ethyl stearate used therein |
| 09/08/1999 | EP0940137A1 Lip care composition containing acexamic acid and uses |
| 09/08/1999 | EP0939670A1 Novel compositions with alkylglycoside and fatty alcohol base |
| 09/08/1999 | EP0939655A1 Stable protein and nucleic acid formulations using non-aqueous, anhydrous, aprotic, hydrophobic, non-polar vehicles with low reactivity |
| 09/08/1999 | EP0939641A1 Topical products as prophylactic or curative agents for bacterial skin infections |
| 09/08/1999 | EP0939640A1 Improvements in polymer compositions for chemotherapy and methods of treatment using the same |
| 09/08/1999 | EP0939638A1 Injectable formulations of avermectins and milbemycins |
| 09/08/1999 | EP0939635A1 Improved intraocular irrigating solution containing a polyamine antagonist |
| 09/08/1999 | EP0939631A1 Use of mupirocin for the manufacture of a medicament for the treatment of bacterial infections associated with colonisation of the nasopharynx by pathogenic organisms |
| 09/08/1999 | EP0939626A1 Galenic formula with extended release of milnacipran |
| 09/08/1999 | EP0939624A1 Effervescent bisphosphonate formulation |
| 09/08/1999 | EP0939623A1 Oral delayed immediate release formulation and method of preparation therefor |
| 09/08/1999 | EP0939622A1 Porous microcapsules and their use as therapeutic and diagnostic vehicles |
| 09/08/1999 | EP0939621A1 Inhibition of bcl-2 protein expression by liposomal antisense oligodeoxynucleotides |
| 09/08/1999 | EP0939608A1 A device and method for acidic buffering |
| 09/08/1999 | EP0830128A4 Compositions and methods useful for inhibiting cell death and for delivering an agent into a cell |
| 09/08/1999 | EP0793517B1 Device for enhancing electrotransport agent delivery |
| 09/08/1999 | EP0724430B1 Method for the formation of liposomes and compositions for use therein |
| 09/08/1999 | EP0670713B1 A pharmaceutical formulation |
| 09/08/1999 | CN2336795Y Reinforced plaster with incorporated medicaments |
| 09/08/1999 | CN1228109A Gelling agent and gel compositions |
| 09/08/1999 | CN1228028A Use of histamine for therapeutic purposes |
| 09/08/1999 | CN1228022A Parenteral paclitaxel stable non-toxic formulation |
| 09/08/1999 | CN1228021A Compositions comprising microparticles of water-insoluble substances and method for preparing same |
| 09/08/1999 | CN1228020A Multi-layered osmotic device |
| 09/08/1999 | CN1228019A Granulates comprising water soluble compound and cellulose |
| 09/08/1999 | CN1228018A Liposomal compositions and method of using them |
| 09/08/1999 | CN1227748A Process for preparing ultramicro infant medicine |
| 09/08/1999 | CN1227743A Trovafloxacin mesylate tablet |
| 09/08/1999 | CN1044973C Burn ointment |
| 09/08/1999 | CN1044971C Preparation method of Dantian heart-strengthening plaster |
| 09/08/1999 | CN1044970C Process for preparing chicken bile oral liquor |
| 09/07/1999 | US5948825 Microemulsion preparation containing a slightly absorbable substance |
| 09/07/1999 | US5948818 Treatment of inflammatory bowel disease using oral dosage forms of omega-3 polyunsaturated acids |